News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Akron Biotechnology, LLC Announces the Launch of: CryoSolve – A Single-Use cGMP Cell Cryopreservation Media
January 29, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOCA RATON, Fla.--(BUSINESS WIRE)--Akron Biotech is proud to announce the launch of CryoSolve, a cGMP single-use cell cryopreservation media, containing DMSO USP/EP 55% w/v, Dextran-40 USP/EP 5% w/v and WFI, with a 10% final DMSO concentration.
Twitter
LinkedIn
Facebook
Email
Print
Akron Biotech